British drug giant AstraZeneca has paused a planned £200 million expansion of its research site in Cambridge, the company said.
It comes after the pharmaceutical firm abandoned plans to invest £450 million in a vaccine plant in Merseyside earlier this year in a blow to the Government as it seeks to stress its commitment to growing the economy and making the country more attractive to international investors.
